MLL2 Complex is a complex catalyzing the transcription-activating methylation of histone H3 lysine-4 and comprising a catalytic, SET domain-containing subunit, MLL2, plus the subunits of an activity-enhancing sub-complex—WDR5, RbBP5, Ash2L and DPY-30 (2 copies). MLL2 expression is elevated in breast and colon cancer cell lines and in both breast and colon tumor tissue, suggesting that MLL2 Complex may represent a therapeutic target for these cancers and possibly solid tumors in general.
ACCESSION #: NM_003482, NM_017588, NM_005057, NM_001105214, NM_0325742
INCLUDES AMINO ACIDS: MLL2 5319-5537 (C-term.), WDR5 22-334 (C-term.), RbBP5 1-538 (C-term.), Ash2L 2-534 (C-term.), DPY-30 1-99 (C-term.)
TAG(S): N-terminal His-tag on all subunits
MW: 211.0 kDa
EXPRESSION SYSTEM: E. coli
SUPPLIED AS: Solution of purified recombinant proteins in 20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM TCEP (tris(2-carboxyethyl)phosphine HCl), 10% (w/v) glycerol, 1 µM ZnCl2.
STORAGE: -80°C, aliquot and snap-freeze after first use.
View Product Data Sheet
Substantial Discounts Available on Bulk Quantities
We also offer assay services for MLL2 Complex.